Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Citrulline for Acute Lung Injury in Severe Sepsis
NCT01474863Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Aug 2012
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of citrulline in acute lung injury (ALI), sponsored by Vanderbilt University. Started Aug 2012; status: completed.
02
Drugs
citrulline
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NCT01474863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474863.